Introduction
Glioblastoma multiforme (GBM), a high grade (IV) astrocytoma, remains the most common and lethal primary brain tumor in adults with a median survival of 12-15 months (1) . Clinical management of GBM is largely palliative, due to poor efficacy of conventional therapeutics and reflexive secondary tumor formation following resection. The identification of GBM-associated "cancer stem cells" (CSC) has fueled research into the contributing role of this cell type in GBM pathogenesis and therapeutic resilience (2) . GBM CSCs are capable of self-renewal and multilineage differentiation, enable tumorigenesis upon intracranial implantation within immunocompromised rodents (3) , and exhibit elevated therapeutic resistance relative to bulk glioma cells (4) . Therefore, elucidation of the molecular mechanisms underlying CSC maintenance and proliferation in the tumor microenvironment offers new focus toward the development of improved anti-GBM therapies.
Cell-microenvironment interactions modulate GBM pathogenesis, whereby perivascular localities are particularly important as they support the malignant behavior of CSCs (5, 6) .
Specifically, association with endothelial cells (ECs) or capillary structures supports maintenance of Nestin+ and CD133+ CSCs by sustaining their undifferentiated state and proliferation (5) . Likewise, paracrine signaling by CSCs enhances the apoptotic threshold of ECs (7), thereby preserving the perivascular microenvironment necessary for downstream processes involved in GBM pathology. Nevertheless, despite accumulating evidence confirming the importance of CSC-EC signaling in GBM pathogenesis, the precise molecular mechanisms involved in CSC localization to -and function within -the perivascular niche remain poorly defined.
Interleukin-8 (IL-8) has received significant attention as a pro-migratory and proangiogenic stimulus in multiple cancers, but may regulate GBM-CSC functions as well (8) Author Manuscript Published OnlineFirst on October 11, 2013; DOI: 10.1158/0008-5472.CAN- coupled receptors, CXCR1 and CXCR2, whose expression varies dramatically by cell type and throughout pathogenesis (9) . While initially identified as a monocyte-secreted chemotactic factor for neutro/basophils and T-lymphocytes, IL-8 can similarly facilitate invasion of bulk glioma cells and has been associated with increased tumor grade in astrocytic neoplasms (10, 11) . In addition to its direct pro-angiogenic effects, IL-8 can promote GBM tumor vascularization indirectly by elevating the apoptotic threshold of ECs as well as promoting expression of matrixremodeling enzymes necessary for endothelial sprouting (9, 12) . Although it has been recently revealed that autocrine IL-8 signaling contributes to CSC self-renewal within other tumors of the breast and liver (13, 14) , its impacts on the behavior of GBM CSCs, signaling with ECs of the perivascular niche, and participation in GBM tumor growth have yet to be elucidated.
IL-8 expression and secretion are heavily influenced by 3-D cell-microenvironment
interactions (15, 16) , underscoring the importance of physiologically relevant, three-dimensional (3-D) culture models to study IL-8 signaling as it relates to human CSCs and ECs throughout GBM pathogenesis. We have previously shown that tissue-engineered 3-D culture systems mimic in vivo-like IL-8 expression by recapitulating appropriate microenvironmental conditions including cell-cell and cell-extracellular matrix interactions (15, 16) . Here, we utilized porous, polymeric scaffolds as platforms to investigate the role of paracrine EC signaling on patientderived GBM-CSC pathogenesis in vitro and in vivo. Our findings indicate that IL-8 serves as a critical mediator supporting CSC growth and migration toward ECs, which may partially explain their perivascular co-localization in the GBM tumor microenvironment, thereby offering promise as a novel therapeutic target for the clinical management of the disease. Furthermore, these studies undrescore the importance of appropriate culture systems in studying tumor-stroma interactions and support that tissue-engineered models are suitable to evaluate microenvironmentally regulated paracrine signaling in vitro and in vivo.
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Materials and Methods

Cell Culture
Immortalized human brain ECs (hCMEC, provided by Dr. Babette Weksler, Weill Cornell Medical College(17)) were cultured on collagen-coated (1%) flasks in Clontecs EGM-2 media (Lonza). Patient-derived GBM stem cells (CSCs, provided by Dr. John Boockvar, Weill Cornell Medical College) were isolated from GBM tumor specimens (WHO grade IV) as described previously (18) . Briefly, GBM tissue was digested in PBS containing papain (Worthington) and DNAse 1 (Sigma-Aldrich), then titurated via pipette and filtered through a 70ȝm sterile cell filter (BD Biosciences). Cells were resuspended in stem cell media containing 1:1 Dulbecco's Modified Eagle's Medium:F12 (Gibco) plus basic FGF and EGF (each 20ng/mL, Invitrogen) and 1x antibiotic/anti-mycotic (Gibco). An isolated cell was clonally expanded in non-adherent culture flasks and media changed every 48-72 hours, resulting in neurosphere aggregates. Two GBM CSC cell populations, labeled CSC 248(EGFR+/PTEN+) and CSC 974 (EGFR+/PTEN-), were utilized. Expression of stem cell markers Nestin, Sox2, Oct4, and Musashi-1, GFAP, and Bim-1 and absence of Olig-1, Tuj-1, and NeuN were verified via immunocytochemistry, and tumorigenicity confirmed via implantation into athymic mice (18 (to allow cell permeation), scaffolds were placed on ice until implantation. Alternatively, media was to scaffolds under dynamic conditions using an orbital shaker for in vitro experiments.
Animal Studies
Animal studies were performed according to approved protocols by the Cornell University For in vivo studies, tumors were removed and fixed overnight in 4% PFA, then bifurcated and half submitted for paraffin sectioning (4μm) and subsequent H&E staining; remaining half was immersed in 20% sucrose/PBS overnight, embedded in OCT, and cryosectioned (14μm). Immunostaining was performed as above to detect stem cell marker levels; in addition, species-specific EC marker CD31 was probed (mouse anti-human, Invitrogen; rat anti-mouse, BD Pharmingen) at 1:200 dilution, followed by secondary Alexafluor 546 (goat anti-mouse) or Alexafluor 647 (goat anti-rat) antibody at 1:500 (both from Invitrogen).
Sections were counterstained with DAPI (1:5000) and imaged on a Zeiss LSM 710 confocal microscope.
Conditioned Media Preparation
hCMEC-seeded PLG scaffolds were cultured for 3 days, after which EGM-2 media was removed, scaffolds washed in sterile PBS, and basal EBM-2 media (sans growth supplements, with 0.25% FBS and 0.1% penicillin/streptomycin) added. Media was collected at 24 hours and IL-8 ELISA (R&D systems) performed per manufacturer's instructions. Subsequently, media was concentrated 10x at 4C using Amicon Ultrafree 15 centrifugal filter units (3000 MWCO, Millipore). Concentrated media (termed "3-D EC-conditioned medium") was normalized to DNA content, as determined by fluorimetric DNA assay (Quantifluor assay, Promega) of scaffold lysates in Caron's buffer. To generate 2-D-conditioned EC medium, hCMECs were cultured as sub-confluent monolayers and media collected, concentrated, and normalized to like DNA concentrations as above described for 3-D conditioned media. Basal control medium was
Research. generated by incubating basal EBM-2 media for 24 hours at 37C and concentrating 10-fold as above described. Prior to use, conditioned media were diluted to 2x final concentration in stem cell medium and supplemented to CSC cultures for three days of preconditioning prior to subsequent analyses.
Conditioned CSC medium was created by culturing CSCs in non-adherent flasks until neurospheres of ~100μm formed, at which point media was replaced with fresh stem cell medium lacking antibiotics. Media was then concentrated and normalized to DNA content as above described.
Transwell Migration Assay
Transwell inserts (Falcon HTS FluroBlok Inserts, 8μm pore size) were coated with 1% collagen I (BD Biosciences), washed, and placed in 24-well plates. Dissociated CSCs (10,000; with or without prior preconditioning in 3-D EC-conditioned media) were added to each Transwell in 300μL stem cell media and migration assessed following addition of recombinant human IL-8 or IgG (50 or 5ng/mL, Genescript) to stem cell media in the lower compartment. Alternatively, migration towards EC-secreted factors was determined by adding 300μL medium composed of equal parts stem cell medium and either 10x 3-D EC medium or 10x basal EC medium. To confirm the role of IL-8 in CSC chemotaxis, antagonist antibodies to human IL-8 (7.5 μg/mL), CXCR1 (2 μg/mL), or CXCR2 (2 μg/mL, all from R&D Systems) were added prior to the start of the experiment (anti-IL-8 added to medium; anti-CXCR1/2 added to cells+medium for 1 hour at RT prior to experiment). After 16 hours, Transwells were fixed in 4% PFA and DAPI stained TRCN0000009137, TRCN0000009138, Sigma-Aldrich). Additionally, CXCR2 knockdown was confirmed at the protein level using Western Blot analysis. CSCs previously transduced with siRNA-control or siRNA-expressing lentiviruses were centrifuged and harvested at 4C in RIPA buffer containing protease and phosphatase inhibitors (Roche). Protein concentrations were assessed by BCA assay (Pierce), 50μg separated on a pre-cast 10% polyacrylamide gel (BioRad), and then transferred to a PVDF membrane (Bio-Rad). Membranes were blocked with 5% non-fat dry milk for 1 hour, then probed with mouse anti-human CXCR-2 (R&D systems, 1:200) and Į-tubulin (Genscript, 1:5000) antibodies followed by goat anti-mouse HRP secondary antibodies. Densitometric analysis of bands was performed with ImageJ (NIH).
Statistical Analysis
All experiments were performed three separate times and data reported as mean ± SD. Oneway analysis of variance (ANOVA) followed by the Tukey post-test were performed to conclude statistical significance, with Į=0.05, using Prism 5 software (Graphpad).
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Results
In vivo tumor formation by CSC-seeded 3-D polymeric scaffolds recapitulates clinical features of human GBM and is accelerated by EC signaling.
To study the contributions of the 3-D microenvironment and EC signaling on CSC behavior, CSCs from patient GBM resections were utilized. These cells were cultured in non-adherent flasks under typical stem cell culture conditions over multiple passages and formed characteristic neurospheres that robustly expressed stem cell markers Sox2, Nestin, and Oct4 (Fig. 1A) and were capable of multi-lineage differentiation under serum-containing conditions (Supplemental Fig. S1 ). Using this undifferentiated CSC population, we first wanted to confirm that co-implantation of human CSCs with human brain ECs (hCMECs) within highly porous PLG scaffolds enhances GBM formation relative to that of CSCs alone. Indeed, longitudinal measurements of tumor and scaffold volumes via high-resolution ultrasound demonstrated that CSCs implanted together with hCMECs exhibited significantly accelerated tumor formation as compared to CSCs alone by 8-11 weeks (Fig. 1B) . Since blank control scaffolds were largely degraded (~80%) by six weeks, final tumor volumes were due to differences in cell number rather than scaffold contributions (Fig. 1C) . Furthermore, ultrasound analysis revealed multiple regions of blood flow throughout the mass suggesting that neoplasms derived from coimplantation were highly vascularized (Supplemental Fig. S2A ), which is consistent with human GBM.
Following explantation, tumors were subjected to histological analysis to confirm that the subcutaneous PLG implantation model mimicked bona fide GBM. Evaluation of H&E-stained cross-sections demonstrated that tumors contained extensive necrotic cores, which were circumscribed by large pseudo-palisading nuclei (Fig. 1D) , both considered clinical markers of human GBM (21) . Furthermore, frequent microvascular hyperplasia (Supplemental Figure S3A ). Similarly, these vessels borne from co-implantation appeared larger than those observed in tumors formed from by CSC implantation alone; however, the extent of tumor vascularization was similar between both groups (Supplemental Figure S3B) .
Interestingly, Sox2
+ ( Fig. 1F ) and Oct4 + (Supplemental Fig. S3C ) CSCs were detected largely in close or direct proximity to these capillary structures and associated more frequently with portions of the vessels that contained human ECs (Fig. 1F ) suggesting the establishment of perivascular niches supportive of CSC maintenance in our model.
3-D microenvironmental conditions stimulate EC secretion of paracrine factors that support CSC functions in vitro.
To specifically isolate the paracrine signaling effects of hCMECs on CSC-mediated gliomagenesis in our model, we next performed in vitro studies in which hCMECs were cultured in PLG scaffolds to recapitulate their 3-D interactions within the vasculature. Cells adhered readily within the pores of the scaffolds and arranged into capillary tube-like structures that matured over sustained culture periods ( Fig. 2A) , demonstrating the ability of our model to 
Sox2 than conditioned media from 2-D hCMEC cultures or basal medium, where Sox2 expression was minimal and Nestin expression nearly absent (Figs. 2C-D) . Furthermore, 3-Dderived hCMEC signaling factors also accelerated CSC growth in vitro. This was evidenced by larger neurosphere size in cultures supplemented with media from 3-D-cultured hCMECs, which was further corroborated by an almost 3-fold increase in total DNA relative to similar cultures fortified with conditioned media from 2-D hCMEC cultures (Fig 2E) . In light of the heterogeneous stem cell marker expression, cultures supplemented with 2-D conditioned media likely contain a mixed population of CSCs (Fig. 2C ) making the differences in neurosphere area and DNA content seem even more dramatic. This was substantiated by the presence of frequent plate adhesion of glial-like cells in CSC cultures receiving 2-D conditioned media, which was nearly absent in similar cultures fortified with 3-D factors (Supplemental Fig. S4 ). Collectively, these data suggest that 3-D microenvironmental conditions play a pivotal role in mediating paracrine signaling by hCMECs which support CSC maintenance and growth.
Interleukin-8 regulates the migration and growth of GBM CSCs.
Three-dimensional culture conditions can increase IL-8 expression and secretion in various 3-D culture formats (15, 19, 24) . Furthermore, IL-8 reportedly plays important roles in GBM angiogenesis (9), glioma and tumor-associated EC motility (11, 25) , and non-GBM CSCs selfrenewal and pluripotency (13, 14) . Therefore, we next hypothesized that greater CSC growth and maintenance in response to 3-D hCMEC-conditioned media may be related to elevated IL-8 availability. Indeed, 3-D cultured hCMECs secreted significantly more IL-8 relative to the same number of cells maintained in 2-D monolayers (Fig. 3A) . Interestingly, exposure of 3-D hCMEC cultures to soluble factors secreted by CSCs further enhanced IL-8 secretion by these cells.
Together, these data demonstrate a supportive role for 3-D cell-microenvironment interactions on EC-derived IL-8 concentrations within the perivascular microenvironment (Fig. 3A) .
Research. To better define the direct contributions of IL-8 to CSC migration and growth (i.e., two parameters regulating CSC recruitment to and maintenance within the perivascular niche), we performed studies with recombinant human IL-8. The chemotactic ability of IL-8 on CSCs was assessed with a Transwell migration assay using two separate, patient-derived CSC populations. In both cases, IL-8 increased migration of CSCs 5-to 10-fold from control groups challenged with control media (Fig. 3B) , which was preserved to a lesser, yet significant, extent with a 10-fold reduction in IL-8 concentration (Supplemental Figure S5A) . To analyze whether IL-8 stimulation similarly accelerates CSC growth, patient-derived GBM CSCs were cultured in typical stem cell medium in the presence or absence of human IL-8. Addition of IL-8 elicited a dose-dependent increase in neurosphere size of CSCs, which plateaued at 50ng/mL (data not shown) (Fig. 3C ). To confirm that this effect was mediated via binding to the cognate IL-8 receptors CXCR1 and/or CXCR2(9), CSCs were incubated with the respective antagonist antibodies prior to IL-8 treatment. CXCR1 blockade abolished IL-8-induced proliferation and resulted in CSC growth, which matched that of control cultures, suggesting that this receptor is partly responsible for the proliferative effects of IL-8 on CSCs (Fig. 3C) . Interestingly, selective impairment of CXCR2 binding more dramatically impacted CSC growth: cell numbers dropped below controls and even below cell numbers at the start of the experiment (data not shown).
This indicates that (i) signaling via this receptor is necessary for normal CSC viability and (ii)
CSC functions may partly depend on autocrine IL-8 signaling (Fig. 3C) . To confirm the functionalization of IL-8 on CSC growth, saturating levels of an antagonist IL-8 antibody were introduced into cultures that were concomitantly stimulated with IL-8. Again, CSC numbers decreased to levels observed with CXCR2 blockade, further supporting that IL-8 signaling is necessary for both maintenance and proliferation of GBM CSCs (Fig. 3C) .
Paracrine communication between brain ECs and CSCs enhances IL-8 signaling and facilitates CSC migration and growth in vitro.
Research. process. Therefore, to directly assess the contributions of IL-8 stimulation and/or CXCR1/2 binding on cell migration, antagonist antibodies to each were incorporated in repeat Transwell assays. Selective inhibition of IL-8 in 3-D-conditioned hCMEC media, strongly decreased migration of pre-conditioned GBM CSCs, thereby demonstrating that signaling cascades initiated by this factor are pivotal to CSC chemotaxis (Fig. 3F) . Likewise, when cells were treated with antagonists to either CXCR1 or CXCR2, CSC migration was similarly attenuated, establishing that signaling through both receptors functions to facilitate CSC migration.
Interestingly, CXCR2 inhibition appeared to have a greater impact on CSC invasion than did CXCR-1 blockade, yet these results were not statistically significant. Importantly, the impact of these antagonist antibodies was specific to IL-8 signaling, as treatment with IgG control antibody elicited no effect on CSC migration (Supplemental figure S5C) . These data implicate both receptors in CSC migration towards EC-secreted IL-8 within the perivascular microenvironment.
Lastly, the functional significance of 3-D hCMEC-mediated CXCR1 and CXCR2 upregulation on CSC growth was evaluated. To this end, pre-conditioned CSCs were cultured in the presence or absence of selective antagonists to IL-8 or its cognate receptors. Similar to the migration findings above, blockade of either receptor significantly impaired the effects of preconditioning on CSC growth (Fig. 3F) . Similarly, direct blockade of IL-8 also impaired the effects of preconditioning with 3-D hCMEC-derived factors on CSC proliferation, further implicating that the stimulatory effects of paracrine EC signaling on CSC growth are mediated through IL-8 binding to both CXCR1 and CXCR2. Thus far, these results provide corroborating evidence that IL-8 signaling is a critical mediator of GBM CSC migration, maintenance, and growth. Therefore, to directly assess whether IL-8 receptor signaling in GBM CSCs underlies tumor formation siRNA-based inhibition strategies were used. Given the more pronounced effect of CXCR2 in IL-8-mediated CSC growth (Fig.   3C ), siRNA sequences targeted against human CXCR-2 were generated and incorporated into lentiviruses to stably knock-down expression of this receptor (Supplemental Fig. S6A ). Cotransduction of three constructs in GBM CSCs caused a robust (~80%, Supplemental Fig. S6B) knockdown of CXCR2 expression and protein levels (~65%, Supplemental Figure S6C ) with no impact on expression of CXCR1 (data not shown). Next, transduced or native cells were seeded alone or in combination with hCMECs in PLG scaffolds, which were then subcutaneously implanted in SCID mice.
Co-implantation of native CSCs with hCMECs recapitulated prominent tumor formation by 8 weeks, whose volume dramatically exceeded that of tumors borne by CSC implantation alone (Fig. 4A, B) . However, these effects were abolished with CXCR2 knockdown, whereby the volume of tumors formed by transduced GBM CSCs was half that of those generated by native CSCs (Fig. 4B ). Despite this difference in size, these tumors were vascularized to a similar extent as those resulting from native CSC implantation ( Supplementary Fig. S7 ), supporting that differences in tumor growth were not merely the result of stunted tumor perfusion. Importantly, co-implantation of hCMECs with CXCR2 knockeddown CSCs failed to reverse these effects or accelerate tumor formation (Fig. 4B) , thus providing strong evidence that the promoting effects of brain ECs on GBM CSC-dependent tumor growth are mediated in large part through CXCR2 signaling.
Discussion
Delineating the signaling pathways that regulate CSC maintenance, proliferation, and tumorigenicity in the perivascular niche have proved challenging due to a paucity of in vitro models which faithfully recapitulate 3-D microenvironmental conditions. In this study, we utilized a scaffold-based culture system that enables brain ECs to form vascular networks, thereby initiating paracrine IL-8 signaling cascades, which enhance CSC maintenance and growth in vitro and tumor formation in vivo.
The detected upregulation of IL-8 in our studies may have been caused by a variety of microenvironmental conditions including altered dimensionality (15) , direct cell-cell contact (26) , and cell-ECM interactions (27) . Furthermore, varied intraculture oxygen-concentrations could have been involved (28) , whereby this response is regulated by changes in cell morphology that may result from varied culture dimensionality (29) , as well as pathological consequences of cell death (e.g., necrosis) (30) . Moreover, reciprocal interactions between various GBM-associated cell types modulate this response. For example, GBM-associated ECs exhibit enhanced expression of IL-8(31). Accordingly, hCMECs pre-exposed to conditioned media from GBM CSCs increased IL-8 production in our studies (Fig. 3A) , suggesting that CSC-derived signaling is partly responsible for the altered gene expression observed in GBM-derived primary ECs(31).
It is unknown whether the concentrations of IL-8 secreted by ECs in our study are sufficient to effect CSC functions as we observed, given that these latter experiments were performed using a considerably higher IL-8 stimulus. However, ECM in the tumor microenvironment can function indirectly to enhance local IL-8 concentrations to levels that approach those used in our studies.
For example, components of the ECM such as heparin and heparan sulfate can efficiently bind IL-8 via its heparin-binding domains(32) thereby creating signaling depots which contribute to enhanced cell chemotaxis (33) . Future quantitative analysis of spatial differences in IL-8 from ex vivo tumor samples would help to evaluate this possibility.
Research. (Fig. 3A) .
We have shown that both cognate receptors CXCR1 and CXCR2 participate in the growth-and migratory-inducing effects of IL-8 on CSCs.
These findings agree with observations in human microvascular ECs, where blockade of either receptor attenuated chemotaxis towards IL-8(37). However, with regards to cell growth, our data indicate a far greater impact of CXCR2 blockade, which resulted in declining cell counts below control culture levels (Fig. 3C ). This may be partially explained by the broader range of signaling molecules, which can bind to this receptor (9) . Alternatively, the specific downstream effectors of CXCR2 may be critical to IL-8-induced CSC growth. Included in these are activation of phosphoinositide 3-kinase (PI-3K) and extracellular signal-regulated kinase (ERK) 1/2(38), which have been implicated in the proliferation and differentiation of neural stem cells (39) , respectively.
Author Manuscript Published OnlineFirst on October 11, 2013; DOI: 10.1158/0008-5472. CAN-13-1355 Interestingly, PTEN has also been shown to be a potent regulator of PI-3K signaling and has been implicated in the maintenance of various cancer stem cell types (40, 41) . However, in our studies both PTEN + and PTEN -CSCs responded similarly to 3-D EC conditioned media (Fig.   2C ), suggesting that CXCR2-mediated signaling may invoke similar signaling pathways as PTEN, possibly through PI-3K activation.
While this study was specifically designed to better define the role of EC-derived soluble factors on CSC functions the presented culture model may be broadly applicable to other questions of GBM perivascular niche interactions. For example, CSCs may promote tumor growth by modulating blood vessel functions through differentiation into ECs (42) or pericytes (43) . Future studies involving direct co-culture of both cell types within the presented scaffold system may help to better define the underlying molecular and cellular mechanisms and assess whether altered IL-8 signaling may contribute to these changes. Furthermore, the composition and mechanical properties of EC-deposited ECM likely play key roles in guiding CSC, but were not considered in the current study. ECs assemble an ECM that is enriched in laminin α2, a promotor of CSC malignancy (44) . As both laminin α2 and IL-8 inversely correlate with patient survival (44, 45) and are upregulated in GBM-associated ECs relative to normal brain ECs (25, 44) it is provocative to consider that a functional link between these two factors exists. Finally, ECM mechanical properties not only critically impact glioma migration (46) It is critical to note that while subcutaneous co-implantation of CSCs with ECs mimicked certain GBM-like characteristics in vivo, CSCs implanted alone failed to recapitulate advanced tumors within the timespan of the experiment (11 weeks). These findings appear in contrast with other animal models of GBM, e.g., intracranial CSC implantation, which demonstrate rapid tumor formation by these cells, and would thus suggest that additional signaling parameters not afforded by the scaffold model or subcutaneous environment are involved in CSC-mediated tumorigenesis (51) .
As it is possible that varied vascular density contribute to these differences (52) , future studies will be required to evaluate the importance of IL-8 signaling in an orthotopic or transgenic model of GBM. Research.
